- Clinical characteristics of 2,459 severe or critically ill COVID-19 patientsZhimei, Zhong; Hongyuan, Li; Jieyun, Zhu; Pan, Ji; Bocheng, Li; Jielong, Pang; Jianfeng, Zhang; Xiangdong, LiangMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e23781.
- No Evidence Indicates Famotidine Reduces the Risk of Serious Disease in COVID-19 Patients After Propensity Score Matching: Meta-Analysis and Systematic ReviewsLi, Weizheng*; Dong, Yongxue; Lei, XianmeiDigestive Diseases and Sciences, 2022, 67(1): 351-353.被引 1
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseasePeter Richardson; Ivan Griffin; Catherine Tucker; Dan Smith; Olly Oechsle; Anne Phelan; Justin StebbingLancet, 2020, 395(10223): e30-e31.
期刊论文
Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID‐19
11阅读
